Menu Search
Equities

Lotus Pharmaceuticals Inc

LTUS:PKC

Lotus Pharmaceuticals Inc

Actions
  • Price (USD)0.0038
  • Today's Change0.00 / 0.00%
  • Shares traded170.00k
  • 1 Year change-45.71%
  • Beta-0.4359
Data delayed at least 15 minutes, as of Sep 05 2024 16:33 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Lotus Pharmaceuticals Inc's net income fell -12.22% from 16.43m to 14.42m despite revenues that grew 28.71% from 56.48m to 72.70m. An increase in the selling, general and administrative costs as a percentage of sales from 17.97% to 22.23% was a component in the falling net income despite rising revenues.
Gross margin35.10%
Net profit margin2.45%
Operating margin1.14%
Return on assets1.55%
Return on equity1.81%
Return on investment1.71%
More ▼

Cash flow in USDView more

In 2010, cash reserves at Lotus Pharmaceuticals Inc fell by 2.61m. However, the company earned 26.78m from its operations for a Cash Flow Margin of 36.83%. In addition the company used 29.45m on investing activities and also paid in financing cash flows.
Cash flow per share0.1397
Price/Cash flow per share2.65
Book value per share3.58
Tangible book value per share1.76
More ▼

Balance sheet in USDView more

Lotus Pharmaceuticals Inc has a Debt to Total Capital ratio of 5.16%, a lower figure than the previous year's 5.69%.
Current ratio0.5322
Quick ratio0.4428
Total debt/total equity0.0544
Total debt/total capital0.0516
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -18.49%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)42.39
EPS (TTM) vs
TTM 1 year ago		-92.81
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.